文献速递新发突发、热带与寄生虫病

柬埔寨恶性疟原虫分离株中AQ-13与阿莫地喹的交叉耐药

Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该体外研究用[3H]次黄嘌呤摄取法和384孔高内涵成像法,检测了38株恶性疟原虫分离株对AQ-13和去乙基阿莫地喹的敏感性。结果显示,在柬埔寨恶性疟原虫分离株中,氯喹衍生物阿莫地喹与AQ-13存在强交叉耐药(Pearson相关系数0.8621,P<0.0001)。鉴于阿莫地喹在柬埔寨疗效不佳,AQ-13联合方案在阿莫地喹耐药地区可能面临相似的临床疗效风险。

要点

  • 柬埔寨恶性疟原虫分离株中阿莫地喹与AQ-13呈强交叉耐药(r=0.8621)。
  • 阿莫地喹耐药地区使用AQ-13联合方案需警惕疗效降低。
  • 体外[3H]次黄嘌呤摄取和高内涵成像法可用于评估AQ-13敏感性。

核心结论

  • 柬埔寨恶性疟原虫分离株中阿莫地喹与AQ-13存在强交叉耐药,AQ-13在阿莫地喹耐药地区可能疗效不佳。

研究设计与样本

  • 体外研究,采用[3H]次黄嘌呤摄取法和384孔高内涵成像法,检测38株恶性疟原虫患者分离株对AQ-13和去乙基阿莫地喹的敏感性。

主要发现

  • 阿莫地喹与AQ-13的交叉耐药呈强相关,Pearson相关系数为0.8621(P<0.0001)。

临床怎么用

  • 在阿莫地喹耐药地区,应谨慎评估AQ-13联合方案的临床疗效,并监测交叉耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Expanding resistance to multiple antimalarials, including chloroquine, in South-East Asia (SEA) urges the development of new therapies. AQ-13, a chloroquine derivative, is a new drug candidate for treating malaria caused by Plasmodium falciparum. OBJECTIVES: Possible cross-resistance between the 4-aminoquinolines amodiaquine, piperaquine and AQ-13 has not been assessed. In vitro parasite growth assays were used to characterize the susceptibility of multidrug-resistant and susceptible P. falciparum patient isolates to AQ-13. METHODS: A [3H]hypoxanthine uptake assay and a 384-well high content imaging assay were used to assess efficacy of AQ-13 and desethyl-amodiaquine against 38 P. falciparum isolates. RESULTS: We observed a strong cross-resistance between the chloroquine derivative amodiaquine and AQ-13 in Cambodian P. falciparum isolates (Pearson correlation coefficient of 0.8621, P < 0.0001). CONCLUSIONS: In light of the poor efficacy of amodiaquine that we described recently in Cambodia, and its cross resistance with AQ-13, there is a significant risk that similar clinical efficacy of AQ-13-based combinations should be anticipated in areas of amodiaquine resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Nardella F, Mairet-Khedim M, Roesch C, et al. Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates. J Antimicrob Chemother. 2021. PMID: 34245274. doi:10.1093/jac/dkab219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。